Transition of Anticoagulants 2016
CorConsult Rx - #Repost @ambcarerx ・・・ Oral Anticoagulants have many chronic indications, most commonly VTE treatment/prophylaxis, atrial fibrillation, and valvular heart disease. VTE & AF can both be treated with either warfarin
Replacing warfarin with a NOAC in patients on chronic anticoagulation therapy - The Hospitalist
Edoxaban in Asian Patients With Atrial Fibrillation: Effectiveness and Safety | Journal of the American College of Cardiology
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
Direct Acting Oral Anticoagulants (DOACs) - Province of British Columbia
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Assessing patient preferences for switching from warfarin to direct oral anticoagulants | Journal of Thrombosis and Thrombolysis
JCM | Free Full-Text | Many Good Reasons to Switch from Vitamin K Antagonists to Non-Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation
Impact of anticoagulants on the clinical outcomes of colonic diverticular bleeding comparing warfarin and direct oral anticoagulants | Scientific Reports
Advantages and Disadvantages of Novel Oral Anticoagulants | DAIC
Switching of antithrombotic therapy | STROKE MANUAL
K. thanavaro the indications and uses of the novel anticoagulants | PPT
Direct Oral Anticoagulants (DOACs) | STROKE MANUAL
Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: An Asian Perspective - ScienceDirect
JCM | Free Full-Text | Choice and Duration of Anticoagulation for Venous Thromboembolism
cardio-met on X: "4) Treatment options for #VTE include initial use of heparin (usually low molecular weight heparin, #LMWH) overlapping with # warfarin, or initial LMWH switching to direct oral anticoagulant (#DOAC) or
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial - The Lancet
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward! | The Egyptian Heart Journal | Full Text
Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population | BMC Cardiovascular Disorders | Full Text
Warfarin patients switching to DOACs or remaining on warfarin. Number... | Download Scientific Diagram
Figure 4 from European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation | Semantic Scholar
Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York
Direct Oral Anticoagulants for Secondary Stroke Prevention - Practical Neurology
